Fuyuan Pharmaceutical (601089.SH): Pioglitazone Metformin Tablets (15mg/850mg) obtained drug registration certificate.

News from Zhitong Finance APP, Fuyuan Pharmaceutical (601089.SH) announced that recently, the company has received the "Drug Registration Certificate" (Certificate No.: 2025S02764) for the Pioglitazone Metformin Hydrochloride Tablets (15mg/850mg) (specifications: each tablet contains 15mg of pioglitazone hydrochloride (as CHNOS) and 850mg of metformin hydrochloride) issued by the National Medical Products Administration (hereinafter referred to as the "NMPA"), approving the production of the drug.